Characteristics of frontotemporal dementia patients with a Progranulin mutation.
about
Phenotypic Heterogeneity of Monogenic Frontotemporal DementiaProgranulin: normal function and role in neurodegenerationTargeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiencyRare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease familiesThe spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegenerationGenetic and clinical features of progranulin-associated frontotemporal lobar degenerationALS and FTLD: two faces of TDP-43 proteinopathy.Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia.Variations in the progranulin gene affect global gene expression in frontotemporal lobar degenerationFrontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Olfactory function in corticobasal syndrome and frontotemporal dementiaBrain progranulin expression in GRN-associated frontotemporal lobar degenerationProminent phenotypic variability associated with mutations in ProgranulinA network of RNA and protein interactions in Fronto Temporal Dementia.Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort.Frontotemporal lobar degeneration: current concepts in the light of recent advances.Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).Update on recent molecular and genetic advances in frontotemporal lobar degeneration.Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations.Alzheimer's disease genetics: from the bench to the clinic.Cellular factors modulating the mechanism of tau protein aggregation.Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.Association between progranulin and beta-amyloid in dementia with Lewy bodies.Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia
P2860
Q26782984-BF299B7B-2361-4B93-8387-186C63335298Q28254281-6DBDA432-66A1-4CF0-8B8E-88EB58771769Q28587955-067DE473-DEFC-4A2A-B8E6-44EC0B8795BBQ28732285-FED0695C-A426-4D5C-8DB6-5833E57E342DQ30495415-B87133D3-9693-434A-90FB-B6D221EBFCBFQ30503638-25FB4B52-D2D1-4856-B603-AB26053AC107Q33571116-93AAA2B3-CDBE-4179-B831-7BD21A3F5B2CQ33955043-109CE0EB-77C1-4438-8F99-3494D6DFBDBAQ33978879-FA8ACD92-B4D0-4507-A04A-41133151A5BAQ34046590-200B1117-9117-4D1D-BDE9-ED113946035FQ34330732-1ED99E43-320D-4DF2-8774-557C13D01713Q35014879-F1A64D26-D636-470C-8A1C-11C2ABDA8C44Q35188858-FC3F5CF8-9F0B-45D7-AEB1-7A2F6DFF1951Q35194634-F41A3345-F40A-4915-8D7A-E7731FAC737BQ36134488-C685A185-1A3F-429B-806E-8866648FFE1BQ36424866-4A96EBE6-42A5-4D44-95BB-6BBDE0041815Q36817228-BA05303D-3270-4F3C-ABCA-EAE7F5C7EAA1Q37138811-B9F9EF28-82D7-427E-A14F-6DCFBB01A8C2Q37205729-E5568DCC-CA53-46A2-9405-663675CA4D95Q37363779-BDCF03D3-7CC8-4B4C-BC53-B9EA431BB2C8Q38225911-E4604EB6-6211-42AE-984E-B8ABDF9334DBQ38350075-A9B6D866-E442-4C37-8819-64C3B5F1EF0DQ38392876-20D0B326-4E5D-42E1-9E1E-8666DA642F6BQ45873297-DE7AA0D6-B6C9-4E75-809F-3233C489C96BQ46441393-95CDBA29-A067-472A-B31E-60D26DD2F886Q48860978-6ED51011-E041-40A3-A707-3C7344FBF469Q51967426-CAF2496C-8AFE-406B-9991-6051AC5E82E3Q56972630-B3D8A67F-F1A9-4C37-9308-88C013E5C398
P2860
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@ast
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@en
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@nl
type
label
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@ast
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@en
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@nl
prefLabel
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@ast
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@en
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@nl
P2093
P2860
P50
P356
P1433
P1476
Characteristics of frontotemporal dementia patients with a Progranulin mutation.
@en
P2093
Bernardino Ghetti
Edward D Huey
Eric M Wassermann
Joshua W Elder
Kyle A Heflin
Matt Baker
Michael C Tierney
Mike Hutton
Salvatore Spina
Stephen L Berger
P2860
P304
P356
10.1002/ANA.20969
P577
2006-09-01T00:00:00Z